ArticleCancer science2026

Bispecific Ligand-Based EphB4 CAR-T Cells Generated Using Ephrin-B2 Show Potent Antitumor Activity Against Lung Adenocarcinoma.

Hirotaka Kumeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.